name: cytoplasm to vacuole transport by the Cvt pathway


name: establishment of protein localisation to Golgi


name: establishment of protein localization to Golgi apparatus


name: low-affinity iron ion transmembrane transport


name: negative regulation of gluconate transport


name: positive regulation of gluconate transport


name: protein localization to nuclear inner membrane


name: negative regulation of homeostatic process


name: positive regulation of homeostatic process


name: hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances


name: positive regulation of cholesterol homeostasis


name: chloramphenicol transmembrane transporter activity


name: polymyxin transmembrane transporter activity


name: fosmidomycin transmembrane transporter activity


name: xenobiotic transmembrane transporter activity


name: benzoate transmembrane transporter activity


name: ferrichrome transmembrane transporter activity


name: chrysobactin transmembrane transporter activity


name: achromobactin transmembrane transporter activity


name: tripeptide transmembrane transporter activity


name: multicellular organismal macromolecule metabolic process


name: glycyl-radical enzyme activating activity


name: cadystin transmembrane transporter activity


name: regulation of STAT protein import into nucleus


name: regulation of STAT protein nuclear translocation


name: negative regulation of STAT protein import into nucleus


name: negative regulation of STAT protein nuclear translocation


name: positive regulation of STAT protein import into nucleus


name: positive regulation of STAT protein nuclear translocation


name: active borate transmembrane transporter activity


name: borate uptake transmembrane transporter activity


name: mitochondrial iron ion transmembrane transport


name: chaperone cofactor-dependent protein refolding


name: induction by symbiont of nodulation, tumor or growth in host


name: induction by symbiont in host of tumor, nodule, or growth


name: induction by symbiont in host of tumor, nodule, or growth containing transformed cells


name: induction of tumor, nodule, or growth containing transformed cells in other organism during symbiotic interaction


name: positive regulation of SMAD protein signal transduction


name: negative regulation of SMAD protein signal transduction


name: regulation of catenin import into nucleus


name: regulation of catenin protein nuclear translocation


name: release of sequestered calcium ion into cytosol by Golgi


name: E3 involved in endoplasmic reticulum-associated degradation


name: ubiquitin protein ligase activity involved in chloroplast disassembly


name: ubiquitin protein ligase activity involved in ERAD pathway


name: ubiquitin modification-dependent histone binding


name: regulation of hepatic stellate cell migration


name: positive regulation of hepatic stellate cell migration


name: negative regulation of hepatic stellate cell migration


name: regulation of hepatic stellate cell contraction


name: positive regulation of hepatic stellate cell contraction


name: negative regulation of hepatic stellate cell contraction


name: regulation of anterograde axonal transport of mitochondrion


name: positive regulation of anterograde axonal transport of mitochondrion


name: negative regulation of anterograde axonal transport of mitochondrion


name: clathrin-dependent endocytosis involved in vitellogenesis


name: regulation of mini excitatory postsynaptic potential


name: positive regulation of mini excitatory postsynaptic potential


name: negative regulation of mini excitatory postsynaptic potential


name: negative regulation of astrocyte activation


name: positive regulation of astrocyte activation


name: all-trans retinol 3,4-desaturase activity


name: all-trans retinal 3,4-desaturase activity


name: all-trans retinoic acid 3,4-desaturase activity


name: positive regulation of 1-phosphatidylinositol-3-kinase activity


name: negative regulation of AMPA receptor activity


name: positive regulation of growth plate cartilage chondrocyte proliferation


name: negative regulation of growth plate cartilage chondrocyte proliferation


name: regulation of formation of radial glial scaffolds


name: regulation of Bergmann fiber biosynthesis


name: negative regulation of formation of radial glial scaffolds


name: negative regulation of Bergmann fiber biosynthesis


name: negative regulation of Bergmann fiber formation


name: positive regulation of formation of radial glial scaffolds


name: positive regulation of Bergmann fiber biosynthesis


name: positive regulation of Bergmann fiber formation


name: glutathione specific gamma-glutamylcyclotransferase activity


name: positive regulation of erythrocyte enucleation


name: negative regulation of erythrocyte enucleation


name: regulation of adenine biosynthetic process


name: fusion of sperm to egg plasma membrane involved in double fertilization forming two zygotes


name: fusion of sperm to egg plasma membrane involved in double fertilization forming a zygote and endosperm


name: protein localization to somatodendritic compartment


name: positive regulation of c-di-GMP signaling


name: negative regulation of c-di-GMP signaling


name: negative regulation of protein K48-linked ubiquitination


name: regulation of protein K48-linked ubiquitination


name: negative regulation of premature acrosome loss


name: establishment of protein localization to plasma membrane


name: positive regulation of heme oxygenase activity


name: negative regulation of heme oxygenase activity


name: regulation of entry into reproductive diapause


name: negative regulation of entry into reproductive diapause


name: positive regulation of entry into reproductive diapause


name: temporomandibular joint articular cartilage development


name: hip joint articular cartilage development


name: mandibular condyle articular cartilage development


name: femoral head articular cartilage development


name: ATP-dependent protein-DNA complex displacement activity


name: regulation of cardiac endothelial to mesenchymal transition


name: positive regulation of cardiac endothelial to mesenchymal transition


name: negative regulation of cardiac endothelial to mesenchymal transition


name: regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity


name: negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity


name: regulation of small molecule metabolic process


name: positive regulation of small molecule metabolic process


name: negative regulation of small molecule metabolic process


name: mitotic cohesin dsDNA (leading strand) loading


name: mitotic cohesin ssDNA (lagging strand) loading


name: regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process


name: negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process


name: positive regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process


name: positive regulation of stress granule assembly


name: negative regulation of stress granule assembly


name: positive regulation of mitotic sister chromatid segregation


name: positive regulation of pheromone response MAPK cascade


name: Extracellular Polymeric Substance Matrix


name: positive regulation of meiotic sister chromatid arm separation


name: regulation of cardiac epithelial to mesenchymal transition


name: positive regulation of cardiac epithelial to mesenchymal transition


name: negative regulation of cardiac epithelial to mesenchymal transition


name: regulation of NFAT protein import into nucleus


name: inhibition of NFAT protein import into nucleus


name: negative regulation of NFAT protein import into nucleus


name: positive regulation of NFAT protein import into nucleus


name: response to high density lipoprotein particle


name: response to high density lipoprotein particle stimulus


name: response to low-density lipoprotein particle


name: response to low-density lipoprotein particle stimulus


name: high-affinity zinc II ion transmembrane import


name: negative regulation of catenin import into nucleus


name: negative regulation of catenin protein nuclear translocation


name: protein-containing complex assembly involved in synapse maturation


name: negative regulation of sphingolipid biosynthesis involved in cellular sphingolipid homeostasis


name: positive regulation of catenin import into nucleus


name: positive regulation of catenin protein nuclear translocation


name: N-methylnicotinate transmembrane transporter activity


name: lysine transmembrane import into vacuole


name: arginine transmembrane import into vacuole


name: negative regulation of energy homeostasis


name: positive regulation of energy homeostasis


name: copper ion import across prospore membrane


name: structural constituent of presynaptic actin cytoskeleton


name: L-glutamate(1-) import across plasma membrane


name: presynaptic actin cytoskeleton organization


name: regulation of exocytic insertion of neurotransmitter receptor to postsynaptic membrane


name: regulation of postsynaptic neurotransmitter receptor internalization


name: regulation of postsynaptic specialization assembly


name: regulation of postsynaptic density assembly


name: regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane


name: regulation of recycling endosome localization within postsynapse


name: regulation of modification of postsynaptic structure


name: regulation of presynaptic dense core granule exocytosis


name: regulation of neurotransmitter loading into synaptic vesicle


name: postsynaptic modulation of chemical synaptic transmission


name: presynaptic modulation of chemical synaptic transmission


name: regulation of presynapse organization and biogenesis


name: regulation of postsynapse organization and biogenesis


name: regulation of retrograde trans-synaptic signaling by trans-synaptic protein complex


name: regulation of trans-synaptic complex mediated retrograde trans-synaptic signaling


name: regulation of retrograde trans-synaptic signaling by endocanabinoid


name: regulation of endocannabinoid-mediated retrograde trans-synaptic signaling


name: regulation of synaptic membrane adhesion


name: trans-synaptic signaling by BDNF, modulating synaptic transmission


name: structural constituent of postsynaptic intermediate filament cytoskeleton


name: postsynaptic intermediate filament cytoskeleton organization


name: postsynaptic spectrin-associated cytoskeleton organization


name: thiosulfate transmembrane-transporting ATPase activity


name: cystathionine gamma-synthase activity (acts on O-phosphohomoserine)


name: demethoxycurcumin synthase activity from feruloylacetyl-CoA


name: peptidoglycan asparagine synthase activity


name: gibberellin A34 carboxyl methyltransferase activity


name: [chondroitin sulfate]-D-glucuronyl 2-O-sulfotransferase activity


name: 3'-O-methyltricetin O methyl transferase activity


name: 3-hydroxyacyl-CoA-acyl carrier protein transferase activity


name: L-idonate 5-dehydrogenase activity (NAD-dependent)


name: nitric oxide reductase activity (NAD(P)H-dependent) activity


name: unsaturated chondroitin disaccharide hydrolase activity


name: in-chain hydroxy fatty acyl-CoA synthetase activity


name: omega-hydroxy fatty acyl-CoA synthetase activity


name: 6-phosphoglucan, water dikinase activity


name: phosphogluco-amylopectin water dikinase activity


name: geraniol kinase activity (ATP-dependent) activity


name: linear malto-oligosaccharide phosphorylase activity


name: cellulose 1,4-beta-cellobiosidase activity (reducing end)


name: homophytochelatin synthase activity (polymer-forming)


name: choline monooxygenase activity (NADP-dependent)


name: gamma-aminobutyrate transaminase (glyoxylate dependent) activity


name: steviol 13-O glucosyltransferase activity


name: steviolbioside glucosyltransferase activity (stevioside forming)


name: steviolbioside glucosyltransferase activity (rebaudioside B forming)


name: stevioside glucosyltransferase activity (rebaudioside A forming)


name: 2-phenylethyl 6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside glucosidase (Yabukita) activity


name: sn-2-glycerol-3-phosphate omega-OH-C22:0-CoA acyl transferase activity


name: sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity


name: anthocyanidin 3-O-glucoside 6''-O-acyltransferase activity


name: anthocyanidin 3-O-glucoside 2''-O-glucosyltransferase activity


name: 8-oxo-dADP diphosphate phosphatase activity


name: kaempferol 3-gentiobioside 7-O-rhamnosyltransferase activity


name: L-threonine O-3-phosphate phosphatase activity


name: 2-oxoglutarate, L-arginine oxygenase (succinate-forming) activity


name: D-mannose 6-phosphate 1-epimerase activity


name: D-galactose 6-phosphate 1-epimerase activity


name: hydroxyproline O-arbinofuranose transferase activity


name: 1-acyl dihydroxyacetone phosphate reductase activity


name: UDP-glucose: N-methylanthranilate glucosyltransferase activity


name: 3-geranylgeranylindole NADPH:oxygen oxidoreductase (10,11-epoxidizing) activity


name: 1-18:1-2-16:0-monogalactosyldiacylglycerol palmitoyl-lipid 7-desaturase activity


name: isopentenyladenine UDP glycosyltransferase activity


name: cis-zeatin UDP glycosyltransferase activity


name: trans-zeatin-O-glucoside UDP glycosyltransferase activity


name: acetyl-coenzyme A:acetyl alcohol acetyltransferase activity


name: gamma-hydroxybutyrate dehydrogenase activity (NAD(P)-dependent


name: UDP-glucose:curcumin monoglucoside glucosyltransferase activity


name: DIMBOA glucoside beta-D-glucosidase activity


name: D-myo-inositol (1,3,4,6)-tetrakisphosphate 2-kinase activity


name: all-trans-geranyl-geranyl diphosphate reductase activity


name: geranylgeranyl-chlorophyll a reductase activity


name: dihydrogeranylgeranyl-chlorophyll a reductase activity


name: tetrahydrogeranylgeranyl-chlorophyll a reductase activity


name: 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis)


name: gibberellin-15(closed lactone form),2-oxoglutarate:oxygen oxidoreductase (3beta-hydroxylating) activity


name: very-long-chain 3-ketoacyl-CoA synthase activity


name: very-long-chain enoyl-CoA reductase activity


name: 6-deoxotyphasterol C-23 hydroxylase activity


name: inositol phosphorylceramide synthase activity


name: sphingolipid very long chain fatty acid alpha-hydroxylase activity


name: sphingolipid long-chain base 4-hydroxylase activity


name: glutarate-semialdehyde dehydrogenase (NADP+) activity


name: UDP-D-glucose:cyanidin 3-(p-coumaroyl)-glucoside 5-O-glucosyltransferase activity


name: 1-18:1-2-16:2-monogalactosyldiacylglycerol desaturase activity (SN2-16:3 forming)


name: 1-18:2-2-16:0-monogalactosyldiacylglycerol desaturase activity (SN2-16:1 forming)


name: 1-18:2-2-16:1-monogalactosyldiacylglycerol desaturase activity (SN2-16:2 forming)


name: 1-18:1-2-18:2-phosphatidylcholine desaturase activity (SN2-18:3 forming)


name: 1-18:2-2-18:2-sn-glycerol-3-phosphocholine desaturase activity (SN2-18:3 forming)


name: alpha-ketoglutarate reductase activity (NADH-dependent)


name: gibberellin A44,2-oxoglutarate:oxygen oxidoreductase activity


name: (Z,E)-alpha- farnesene synthase activity


name: hypoglycin A gamma-glutamyl transpeptidase activity


name: alcohol-forming fatty acyl-CoA reductase activity


name: gibberellin A12,2-oxoglutarate:oxygen oxidoreductase activity (gibberellin A110-forming)


name: norsolorinate anthrone synthase activity


name: nitrilotriacetate monooxygenase activity (FMN-dependent)


name: gibberellin A53,2-oxoglutarate:oxygen oxidoreductase activity (GA97-forming)


name: ethylglyoxal reductase (NADH-dependent, hydroxyacetone-forming) activity


name: beta-galactosidase activity (lactose isomerization)


name: L-glyceraldehyde 3-phosphate reductase activity


name: ribosomal protein S6 glutamate-glutamate ligase activity


name: methyl beta-D-glucoside 6-phosphate glucohydrolase activity


name: inositol phosphorylceramide mannosyltransferase activity


name: 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity


name: 4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity


name: leukotriene C4 gamma-glutamyl transferase activity


name: straight chain (R)-2-hydroxy fatty acyl-CoA lyase activity


name: cellular response to environmental stimulus


name: Mitochondrial tRNA pseudouridine(27/28) synthase


name: protein maturation by [2Fe-2S] cluster transfer


name: protein maturation by [4Fe-4S] cluster transfer


name: assembly of apicomedial cortex actomyosin


name: positive regulation of GABA-A receptor activity


name: negative regulation of GABA-A receptor activity


name: guanine deglycation, methylglyoxal removal


name: regulation of cellular response to osmotic stress


name: regulation of calcineurin-mediated signaling


name: negative regulation of calcineurin-mediated signaling


name: positive regulation of calcineurin-mediated signaling


name: negative regulation of exit from meiosis


name: positive regulation of exit from meiosis


name: G protein-coupled folate receptor activity


name: regulation of cobalamin metabolic process


name: regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway


name: positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway


name: negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway


name: dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity


name: regulation of cell adhesion involved in sprouting angiogenesis


name: negative regulation of cell adhesion involved in sprouting angiogenesis


name: positive regulation of cell adhesion involved in sprouting angiogenesis


name: glial cell projection elongation involved in axon ensheathment


name: regulation of glutamate receptor clustering


name: regulation of (R)-mevalonic acid biosynthetic process


name: negative regulation of (R)-mevalonic acid biosynthetic process


name: positive regulation of (R)-mevalonic acid biosynthetic process


name: negative regulation of mitotic cohesin ssDNA (lagging strand) loading


name: positive regulation of mitotic cohesin ssDNA (lagging strand) loading


name: regulation of mitotic cohesin dsDNA (leading strand) loading


name: positive regulation of mitotic cohesin dsDNA (leading strand) loading


name: regulation of sterol biosynthetic process


name: negative regulation of sterol biosynthetic process


name: positive regulation of sterol biosynthetic process


name: positive regulation of cobalamin metabolic process


name: negative regulation of cobalamin metabolic process


name: negative regulation of store-operated calcium entry


name: positive regulation of store-operated calcium entry


name: positive regulation of aggregation involved in sorocarp development


name: negative regulation of aggregation involved in sorocarp development


name: positive regulation of elastin catabolic process


name: regulation of actomyosin structure organization


name: regulation of cardiac muscle myoblast proliferation


name: negative regulation of cardiac muscle myoblast proliferation


name: positive regulation of cardiac muscle myoblast proliferation


name: positive regulation of mitotic spindle organization


name: regulation of G2/MI transition of meiotic cell cycle


name: negative regulation of G2/MI transition of meiotic cell cycle


name: positive regulation of G2/MI transition of meiotic cell cycle


name: regulation of adenylate cyclase-activating glucose-activated G protein-coupled receptor signaling pathway


name: negative regulation of adenylate cyclase-activating glucose-activated G protein-coupled receptor signaling pathway


name: regulation of nematode male tail tip morphogenesis


name: negative regulation of nematode male tail tip morphogenesis


name: positive regulation of nematode male tail tip morphogenesis


name: negative regulation of pharynx morphogenesis


name: positive regulation of pharynx morphogenesis


name: regulation of cell cycle switching, mitotic to meiotic cell cycle


name: negative regulation of cell cycle switching, mitotic to meiotic cell cycle


name: signal transduction involved in cell cycle switching, mitotic to meiotic cell cycle


name: regulation of actin filament organization


name: negative regulation of actin filament annealing


name: positive regulation of actin filament annealing


name: regulation of blood vessel endothelial cell differentiation


name: positive regulation of blood vessel endothelial cell differentiation


name: negative regulation of blood vessel endothelial cell differentiation


name: regulation of angiotensin-activated signaling pathway


name: negative regulation of angiotensin-activated signaling pathway


name: positive regulation of angiotensin-activated signaling pathway


name: regulation of interphase mitotic telomere clustering


name: negative regulation of interphase mitotic telomere clustering


name: apical constriction involved in ventral furrow formation


name: regulation of apical constriction involved in ventral furrow formation


name: positive regulation of apical constriction involved in ventral furrow formation


name: regulation of placenta blood vessel development


name: positive regulation of placenta blood vessel development


name: negative regulation of placenta blood vessel development


name: regulation of protein localization to cell division site involved in mitotic actomyosin contractile ring assembly


name: positive regulation of protein localization to cell division site involved in mitotic actomyosin contractile ring assembly


name: negative regulation of protein localization to cell division site involved in mitotic actomyosin contractile ring assembly


name: regulation of hippocampal neuron apoptotic process


name: positive regulation of hippocampal neuron apoptotic process


name: negative regulation of hippocampal neuron apoptotic process


name: regulation of calcium import into the mitochondrion


name: positive regulation of calcium import into the mitochondrion


name: negative regulation of calcium import into the mitochondrion


name: L-valine transmembrane import into vacuole


name: ribulose bisphosphate carboxylase complex assembly


name: mRNA cleavage and polyadenylation specificity factor complex assembly


name: plasma membrane bounded cell projection morphogenesis


name: positive regulation of macrophage proliferation


name: negative regulation of macrophage proliferation


name: regulation of protein localization to medial cortical node


name: positive regulation of protein localization to medial cortical node


name: U6 snRNA (adenine-(43)-N(6))-methyltransferase activity


name: positive regulation of small intestinal transit


name: negative regulation of small intestinal transit


name: stomach pylorus smooth muscle contraction


name: pyloric antrum smooth muscle contraction


name: pyloric sphincter smooth muscle contraction


name: regulation of stomach fundus smooth muscle contraction


name: positive regulation of stomach fundus smooth muscle contraction


name: negative regulation of stomach fundus smooth muscle contraction


name: regulation of pyloric antrum smooth muscle contraction


name: positive regulation of pyloric antrum smooth muscle contraction


name: negative regulation of pyloric antrum smooth muscle contraction


name: regulation of endocardial cushion cell differentiation


name: positive regulation of endocardial cushion cell differentiation


name: negative regulation of endocardial cushion cell differentiation


name: cell adhesion involved in sprouting angiogenesis


name: cell adhesion involved in vascular anastomosis


name: endothelial tip cell filopodium assembly


name: regulation of peptidyl-lysine crotonylation


name: negative regulation of peptidyl-lysine crotonylation


name: UDP-glucose transmembrane transport into endoplasmic reticulum


name: cytoplasm to vacuole transport by the NVT pathway


name: positive regulation of apoptotic process in bone marrow cell


name: positive regulation of apoptosis in bone marrow


name: negative regulation of actin cortical patch assembly


name: inhibition of actin cortical patch assembly


name: positive regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity


name: regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity


name: positive regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity


name: negative regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity


name: regulation of ecdysone receptor-mediated signaling pathway


name: positive regulation of ecdysone receptor-mediated signaling pathway


name: negative regulation of ecdysone receptor-mediated signaling pathway


name: protein localization to basal ectoplasmic specialization


name: regulation of mitotic actomyosin contractile ring disassembly


name: positive regulation of mitotic actomyosin contractile ring disassembly


name: calcium-dependent outer dynein arm binding


name: negative regulation of ERBB4 signaling pathway


name: positive regulation of collagen catabolic process


name: activation of collagen catabolic process


name: 23S rRNA pseudouridine(955/2504/2580) synthase


name: intraciliary transport particle A binding


name: regulation of cold-induced thermogenesis


name: positive regulation of cold-induced thermogenesis


name: negative regulation of cold-induced thermogenesis


name: plus-end-directed endosome transport along mitotic spindle midzone microtubule


name: contractile vacuole tethering involved in discharge


name: contractile vacuole tethering to plasma membrane


name: contractile vacuole dissociation from plasma membrane


name: establishment of contractile vacuole localization


name: pore formation during contractile vacuole discharge


name: ubiquitination-like modification-dependent protein binding


name: cell-cell adhesion in response to extracellular stimulus


name: cellular detoxification of methylglyoxal


name: lipid droplet localization to prospore membrane leading edge


name: adiposome localization to forespore membrane leading edge


name: lipid body localization to forespore membrane leading edge


name: lipid particle localization to forespore membrane leading edge


name: manganese ion export across plasma membrane


name: regulation of endocardial cushion to mesenchymal transition


name: negative regulation of endocardial cushion to mesenchymal transition


name: positive regulation of endocardial cushion to mesenchymal transition


name: cellular response to oxidised low-density lipoprotein particle stimulus


name: organelle localization by membrane tethering


name: branching morphogenesis of a neuron projection


name: cardiac endothelial to mesenchymal transition


name: negative regulation of lipoprotein transport


name: positive regulation of lipoprotein transport


name: class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity


name: ATP-dependent protein-DNA unloader activity


name: high-affinity potassium ion transmembrane transporter activity


name: high-affinity glucose transmembrane transporter activity


name: [choline trimethylamine-lyase]-activating enzyme activity


name: negative regulation of Lewy body formation


name: positive regulation of Lewy body formation


name: positive regulation of lymphocyte chemotaxis


name: suppression by symbiont of host cytokine secretion


name: mechanosensitive monoatomic cation channel activity


name: mitochondrial guanine nucleotide transmembrane transport


name: mitochondrial potassium ion transmembrane transport


name: regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process


name: regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process


name: negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process


name: positive regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process


name: positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process


name: negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process


name: adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate


name: spermidine import across plasma membrane


name: oligopeptide import across plasma membrane


name: tripeptide import across plasma membrane


name: apoptotic process in response to mitochondrial fragmentation


name: zinc ion import into endoplasmic reticulum


name: protein transport along microtubule to kinetochore


name: regulation of long-chain fatty acid import into cell


name: negative regulation of long-chain fatty acid import into cell


name: positive regulation of long-chain fatty acid import into cell


name: regulation of D-aspartate import across plasma membrane


name: negative regulation of D-aspartate import across plasma membrane


name: positive regulation of D-aspartate import across plasma membrane


name: regulation of spontaneous synaptic transmission


name: clathrin-dependent synaptic vesicle endocytosis


name: regulation of neuron projection arborization


name: positive regulation of neuron projection arborization


name: negative regulation of neuron projection arborization


name: oxidised low-density lipoprotein particle clearance


name: oxidised low-density lipoprotein particle receptor activity


name: oxidised low-density lipoprotein receptor activity


name: regulation of protein localization to lysosome


name: positive regulation of protein localization to lysosome


name: negative regulation of protein localization to lysosome


name: regulation of trans-synaptic signaling by BDNF, modulating synaptic transmission


name: regulation of trans-synaptic signaling by endocannabinoid, modulating synaptic transmission


name: regulation of calcium-dependent activation of synaptic vesicle fusion


name: postsynaptic dense core vesicle exocytosis


name: structural constituent of synapse-associated extracellular matrix


name: regulation of postsynaptic dense core vesicle exocytosis


name: regulation of synaptic signaling by nitric oxide


name: G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential


name: regulation of postsynaptic neurotransmitter receptor diffusion trapping


name: regulation of glycine import across plasma membrane


name: regulation of NF-kappaB import into nucleus


name: negative regulation of NF-kappaB import into nucleus


name: negative regulation of cytoplasmic NF-kappaB storage


name: positive regulation of NF-kappaB import into nucleus


name: release of cytoplasmic sequestered NF-kappaB


name: release of NF-kappaB sequestered in cytoplasm


name: malonic acid uptake transmembrane transporter activity


name: oleate transmembrane transporter activity


name: carbohydrate derivative transmembrane transporter activity


name: establishment of protein localisation in prospore membrane


name: protein targeting to ascospore-type prospore membrane


name: regulation of establishment of protein localization in plasma membrane


name: regulation of protein targeting to plasma membrane


name: down regulation of protein targeting to plasma membrane


name: inhibition of protein targeting to plasma membrane


name: negative regulation of establishment of protein localization in plasma membrane


name: negative regulation of protein targeting to plasma membrane


name: activation of protein targeting to plasma membrane


name: positive regulation of establishment of protein localisation in plasma membrane


name: positive regulation of protein targeting to plasma membrane


name: up regulation of protein targeting to plasma membrane


name: regulation of autophagy of mitochondrion


name: negative regulation of autophagy of mitochondrion


name: negative regulation of sodium ion export


name: positive regulation of sodium ion export


name: release of sequestered calcium ion into cytosol by endoplasmic reticulum


name: arachidonate transmembrane transporter activity


name: positive regulation of electron transfer activity


name: positive regulation of L-arginine import


name: negative regulation of cartilage homeostasis


name: negative regulation of ubiquitin-dependent protein catabolic process


name: positive regulation of ubiquitin-dependent protein catabolic process


name: negative regulation of signaling receptor activity


name: regulation of protein localization to prospore membrane


name: positive regulation of protein localization to prospore membrane


name: phytochelatin transmembrane transporter activity


name: solanine UDP-galactose galactosyltransferase activity


name: ubiquitin protein ligase activity involved in ER-associated degradation pathway


name: catalytic activity, acting on a glycoprotein


name: histidine transmembrane import into vacuole


name: Diclofenac Sodium;Cream Base NA Multiple Routes Kit


name: syringe with needle, insulin, safety, 0.3 mL 31 gauge X 15/64" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with needle, insulin, safety, 0.5 mL 31 gauge X 15/64" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with needle, insulin, safety, 1 mL 31 gauge X 15/64" MISCELL SYRINGE, EMPTY DISPOSABLE


name: infant formula with iron/docosahexaenoic acid/arachidonic ac 2.1 gram-5.4 gram-10.9 gram/100 kcal ORAL LIQUID (ML)


name: TITANIUM DIOXIDE 3.18 mg in 40 mL / OCTINOXATE 2.716 mg in 40 mL / ZINC OXIDE 2 mg in 40 mL / OCTISALATE 1.8 mg in 40 mL TOPICAL CREAM [Dr.Jart Premium Beauty Balm 01 Light medium]


name: CETIRIZINE HYDROCHLORIDE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: CETIRIZINE HYDROCHLORIDE 99 g in 100 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TITANIUM DIOXIDE 250 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Anthelios 50 Mineral Daily Tone Correcting Primer Broad Spectrum SPF 50 Sunscreen]


name: TITANIUM DIOXIDE 90 mg in 1 mL / ZINC OXIDE 40 mg in 1 mL TOPICAL LOTION [SkinCeuticals Physical Matte UV Defense Broad Spectrum SPF 50 Sunscreen]


name: Nutritional Supplement Oral Liquid [ULTRIENT 1.5]


name: Bifidobacterium animalis / Lactobacillus acidophilus


name: ZINC OXIDE 1.5 g in 30 mL / TITANIUM DIOXIDE 1.5 g in 30 mL TOPICAL LOTION [Sei Bella Tinted BB Moisturizing Creme Deep 550 N]


name: AVOBENZONE 28.5 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTINOXATE 70 mg in 1 mL / OCTISALATE 30 mg in 1 mL / OCTOCRYLENE 90 mg in 1 mL TOPICAL CREAM [Pur Confort SPF 15]


name: Zinc Oxide 175 mg in 1 mL TOPICAL CREAM [Chem-Free Active Defense SPF 30]


name: HYDROQUINONE 0.04 mg in 1 mL TOPICAL EMULSION [ZO Skin Health Pigment Control plus Brightening Creme Hydroquinone plus Vitamin C]


name: Flexichamber Anti-Static Valved Collapsible H


name: TechLITE Insulin Syringe 31 g X 6 mm 0.3 mL


name: TechLITE Insulin Syringe 31 g X 6 mm 0.5 mL


name: TechLITE Insulin Syringe 31 g X 6 mm 1 mL


name: Xeroform Occlusize Petrolatum Gauze Patch 2x2


name: ESTRADIOL BENZOATE 99 g in 100 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TADALAFIL 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TRIPELENNAMINE HYDROCHLORIDE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 18 g in 57 g TOPICAL GEL [Helmm Antiperspirant Deodorant Hudson]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 20 mg in 1 g / OXYBENZONE 40 mg in 1 g TOPICAL AEROSOL, SPRAY [Solimo Sport Sunscreen SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g / OXYBENZONE 50 mg in 1 g TOPICAL AEROSOL, SPRAY [Solimo General Protection Sunscreen SPF 50]


name: TITANIUM DIOXIDE 3.328 mg in 40 mL / OCTINOXATE 2.4 mg in 40 mL / ZINC OXIDE 0.784 mg in 40 mL / OCTISALATE 0.8 mg in 40 mL TOPICAL CREAM [Dr.Jart Black Label Detox Beauty Balm]


name: OCTINOXATE 7.5 g in 100 mL / ZINC OXIDE 9 g in 100 mL TOPICAL CREAM [Neova DNA Damage Control - Active Broad Spectrum SPF 43]


name: AVOBENZONE 18 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [Solimo Sport SPF 30 Sunscreen]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g / OXYBENZONE 50 mg in 1 g TOPICAL AEROSOL, SPRAY [Solimo Kids Sunscreen SPF 50]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [Solimo Sport SPF 50 Sunscreen]


name: OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / HOMOSALATE 130 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL / OXYBENZONE 40 mg in 1 mL TOPICAL LOTION [Solimo General Protection SPF 50 Sunscreen]


name: HYDROQUINONE 0.04 g in 1 mL TOPICAL EMULSION [ZO Skin Health Pigment Control Plus Blending Creme Hydroquinone]


name: hypochlorous acid/sodium hypochlorite/sod chlorid/elec.water 0.012 %-0.002 %-0.046 %-99.94 % TOPICAL SPRAY, NON-AEROSOL (ML)


name: Assure ID 1/2 mL 29G 1/2 inch Insulin Safety Syringe


name: Assure ID 1mL 29G 1/2 inch Insulin Safety Syringe


name: Ensure MAX Protein Nutrition Shake (Cafe Mocha)


name: Ensure MAX Protein Nutrition Shake (Milk Chocolate)


name: Glucocard Expression Blood Glucose Test Strip


name: Glucocard Shine Blood Glucose Test Strip


name: Nutricia SOD Anamix Early Years Powder for Suspension


name: Walgreens Automatic Arm Blood Pressure Monitor System


name: Walgreens Manual Inflate Blood Pressure Kit


name: Walgreens True Focus Self Monitoring Blood Glucose Test Strip


name: Walgreens True Metrix AIR Blood Glucose Meter Kit


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 7 g in 100 mL TOPICAL LOTION [Solar Protection Fluid Broad Spectrum SPF 50]


name: AMLODIPINE BESYLATE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TIOPRONIN 99 g in 100 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ALUMINUM CHLOROHYDRATE 1 g in 100 g TOPICAL STICK [INVISIBLE SOLID ANTI-PERSPIRANT and DEODORANT]


name: ALUMINUM CHLOROHYDRATE 20 g in 100 mL TOPICAL LIQUID [Odorono Antiperspirant and Deodorant Roll-on Original]


name: Homosalate 100 mg in 1 mL / MERADIMATE 50 mg in 1 mL / Octinoxate 50 mg in 1 mL / Octocrylene 20 mg in 1 mL / Zinc oxide 63 mg in 1 mL TOPICAL LOTION [CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen]


name: CATHERIZATION SET,INTERMITTENT 16FR RUSCH #RLA-162-3C


name: CATHETER FOLEY 2-WAY 10FR 3ML PECO #PF5810


name: CATHETER,INTERMITTENT 12FR COLOPLAST #28412


name: CATHETER,INTERMITTENT 18FR COLOPLAST #28418


name: CATHETER,INTERMITTENT COUDE 16FR PECO #PU816C


name: CATHETER,INTERMITTENT,MAGIC3 16FR ROCHESTER #50616


name: DEPEND UNDERWEAR,MAXIMUM ABSORB,MEN LARGE


name: DEPEND UNDERWEAR,MAXIMUM ABSORB,MEN X-LARGE


name: DEPEND UNDERWEAR,MAXIMUM ABSORB,WOMEN MEDIUM


name: DEPEND UNDERWEAR,MAXIMUM ABSORB,WOMEN SMALL


name: LARYNGEAL PROSTHESIS CLEANING BRUSH,PROVOX 4.5-10MM #7204


name: LARYNGECTOMY TUBE BRUSH,8MM PROVOX #7660


name: SUCTION CANISTER 725ML DEVILBISS #DV7310P603


name: syringe w-needle,insulin 0.5 mL (half unit mark)


name: OCTINOXATE 50 mg in 1 g / OCTISALATE 30 mg in 1 g / ZINC OXIDE 30 mg in 1 g TOPICAL CREAM [EB5 Ultra Light Face SPF 15]


name: OCTINOXATE 6 g in 100 mL / ZINC OXIDE 12 g in 100 mL TOPICAL LOTION [SPF 50 Moisturizing Sunscreen Broad Spectrum]


name: OCTINOXATE 3.9 g in 50 mL / ZINC OXIDE 3.8 g in 50 mL TOPICAL LOTION [DECORTE SHEER BRILLIANCE 10]


name: Niacinamide 2.0 g in 100 mL / Adenosine 0.04 g in 100 mL TOPICAL CREAM [MORINGA PURIFY WATER]


name: silicone adhesive 1.4" X 6" TOPICAL STRIP


name: parenteral electrolytes combination no.26


name: parenteral electrolytes combination no.27


name: ZINC OXIDE 190 mg in 1 mL TOPICAL CREAM [LBri Pure n Natural SPF 30]


name: LIDOCAINE 10 mg in 0.08 mL TOPICAL SPRAY [DYNAMO DELAY Black Label]


name: COMBINATION PACK,DROPS AND VISCOUS DROPS


name: diluent for ixabepilone (castor oil/alcohol) 8 mL INTRAVEN VIAL (ML)


name: diluent for ixabepilone (castor oil/alcohol)


name: diluent for ixabepilone (castor oil/alcohol) 23.5 mL INTRAVEN VIAL (ML)


name: nutritional supplement,special formula,lactose free,iron/soy 0.04 gram-1 kcal/mL ORAL LIQUID (ML)


name: OCTINOXATE 7.5 g in 100 mL / OCTOCRYLENE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 2.5 g in 100 mL TOPICAL SPRAY [Kinesys]


name: AVOBENZONE 20 mg in 1 mL / OCTINOXATE 30 mg in 1 mL / OCTOCRYLENE 40 mg in 1 mL TOPICAL EMULSION [La Prairie Skin Caviar Essence In Foundation SPF 25 Golden Beige]


name: ZINC OXIDE 0.6375 g in 4.25 g TOPICAL LOTION [Brandless Lip Balm Coconut Broad Spectrum 15%]


name: Octinoxate 1.19 g in 17 g / Octisalate 0.76 g in 17 g / Octocrylene 0.34 g in 17 g TOPICAL STICK [May New York Super Clear Pure Sun Ultra 17g]


name: BUTYLSCOPOLAMINE BROMIDE 49.5 g in 50 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TYLOSIN 19.8 kg in 20 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: polyethylene glycol 3350 / potassium chloride / sodium chloride / sodium sulfate


name: ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride


name: {1 (ascorbic acid 7540 MG / polyethylene glycol 3350 40000 MG / potassium chloride 1200 MG / sodium ascorbate 48110 MG / sodium chloride 3200 MG Powder for Oral Solution) / 1 (polyethylene glycol 3350 100000 MG / potassium chloride 1000 MG / sodium chloride 2000 MG / sodium sulfate 9000 MG Powder for Oral Solution) } Pack


name: SILDENAFIL CITRATE 24.75 g in 25 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: SILDENAFIL CITRATE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: SILDENAFIL CITRATE 9.9 g in 10 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: SILDENAFIL CITRATE 99 g in 100 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: magnesium glycinate 10 % MISCELL POWDER (GRAM)


name: tolvaptan 45 mg (AM)/15 mg (PM) ORAL TABLET, SEQUENTIAL


name: tolvaptan 60 mg (AM)/30 mg (PM) ORAL TABLET, SEQUENTIAL


name: tolvaptan 90 mg (AM)/30 mg (PM) ORAL TABLET, SEQUENTIAL


name: xanthan gum 96 gram ORAL GEL IN PACKET (GRAM)


name: ZINC OXIDE 80 mg in 1 g TOPICAL STICK [Sun Bum Mineral SPF30 Sunscreen]


name: GLYCERIN 0.0001 g in 100 mL TOPICAL LIQUID [Derma First Mist]


name: GLYCERIN 0.15 g in 100 mL TOPICAL LIQUID [Derma First Ampoule]


name: Silicone Topical application Patch, Extended Release [COATAMAX PATCH]


name: azelastine HCl 100 % MISCELL POWDER (GRAM)


name: Capsaicin/Menthol/Methyl Salicylate;Diclofenac Sodium 0.025%-6%-25%; 50 MG Multiple Routes Kit


name: Capsaicin/Menthol/Methyl Salicylate;Ibuprofen 0.025%-6%-25%; 800 MG Multiple Routes Kit


name: Capsaicin/Menthol/Methyl Salicylate;Nabumetone 0.025%-6%-25%; 500 MG Multiple Routes Kit


name: Ceftriaxone Sodium;Lidocaine/Prilocaine 2 GM; 2.5%-2.5% Multiple Routes Kit


name: Ceftriaxone Sodium;Lidocaine/Prilocaine 2 GM; 2.5%-2.5% Multiple Routes Kit [CEFTRI-IM INJECTION]


name: Ceftriaxone Sodium;Sodium Chloride 2 GM; 0.9% Multiple Routes Kit [CEFTRISOL PLUS]


name: Heparin Sodium;Lidocaine/Prilocaine;Sodium Chloride 100 U/1 ML; 2.5%-2.5%; 0.9% Multiple Routes Kit [HEPMED IV PACK]


name: AMOXICILLIN .99 kg in 1 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: LUFENURON 22.77 kg in 23 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: LUFENURON 24.75 kg in 25 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: PREGABALIN 4.95 kg in 5 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ALUMINUM CHLOROHYDRATE 1 g in 100 g TOPICAL STICK [UNTRA DRY ANTI-PERSPIRANT and DEODORANT -COOL BLAST]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 18.2 g in 100 g TOPICAL STICK [Degree MotionSense White Flowers and Lychee Scent Antiperspirant]


name: Octinoxate 1.05 g in 15 g / Octisalate 0.67 g in 15 g / Octocrylene 0.30 g in 15 g TOPICAL STICK [OrgaPlus Ultra Pure Sun EX 15g]


name: Octinoxate 1.54 g in 22 g / Octisalate 0.99 g in 22 g / Octocrylene 0.44 g in 22 g TOPICAL STICK [OrgaPlus Ultra Pure Sun EX 22g]


name: ALOE VERA LEAF 0.01 g in 100 mL TOPICAL LIQUID [Splendid Betta Complete Water Conditioner]


name: ALOE VERA LEAF 0.01 g in 100 mL TOPICAL LIQUID [API Betta Water Conditioner]


name: Adalimumab;Adalimumab 40 MG/0.4 ML; 80 MG/0.8 ML Subcutaneous Solution


name: Assesses procedure related risk factors for VTE


name: Assesses risk factors for perioperative pressure injury


name: Assesses pain control and pain management


name: Assesses cultural and value components related to pain


name: Assesses the presence of implantable orthopedic hardware


name: Assesses appropriate use of patient safety devices


name: Assesses appropriate use of clinical alarm systems


name: Assesses risk for retained surgical items


name: Evaluates for physical injury to skin and tissue


name: Evaluates involvement in healthcare decision making


name: Establishes peripheral intravenous (IV ) access


name: Manages the length of operative or invasive procedure by planning care


name: RNFA collaborates with healthcare providers to perform certain delegated medical functions


name: Administers prescribed intravenous solutions


name: Administers prescribed medications based on laboratory or point-of-care results


name: Administers prescribed medications based on pain assessment


name: Administers prescribed prophylactic antiemetic medications based on assessment


name: Applies monitoring equipment to manage body temperature


name: Performs venipuncture for blood specimens


name: Manages for signs and symptoms of infection


name: Implements deep breathing and coughing exercises


name: Collaborates with the appropriate health care providers to initiate new treatments or change existing treatments


name: Provides information related to physiological and diagnostic study result variances


name: Implements complementary care interventions


name: Collaborates with patient or designated support person in discharge planning


name: Manages supplies and equipment within safe parameters


name: Collaborates, develops, and implements an individualized plan of care


name: Implements security measures for patient records, belongings, and valuables


name: Provides information related to identified patient risks impacting care


name: Assesses cultural, spiritual and individual values, beliefs and preferences concerning care


name: BMP2, IVS1AS, 2-BP DEL/2-BP INS, -7-2AG/CC, 5-PRIME UTR


name: CYP2C8, ARG139LYS AND LYS399ARG (dbSNP rs11572080 AND dbSNP rs10509681)


name: PEX6, 4-BP DEL, +442TAAA, 3-PRIME UTR (dbSNP rs144286892)


name: PEX6, ARG860TRP (dbSNP rs61753230) AND 4-BP DEL, +442TAAA, 3-PRIME UTR (dbSNP rs144286892)


name: GPNMB, 2-BP DEL, 719TG (dbSNP rs747723062)


name: GPNMB, 4-BP DEL, 877TGTT (dbSNP rs773435101)


name: FARSB, 1-BP DEL/2-BP INS, 1486C/AA (dbSNP SCV000676381)


name: UFM1, 3-BP DEL, -273TCA, PROMOTER (dbSNP rs747359907)


name: ALUMINUM CHLOROHYDRATE 10 g in 100 g TOPICAL AEROSOL [Sure Antiperspirant Deodorant Regular]


name: SILICON DIOXIDE 18.20 g in 130 g / ALCLOXA 0.06 g in 130 g TOPICAL PASTE, DENTIFRICE [MediF Tooth]


name: Senior Tabs Multivitamin/Multimineral Tablet


name: Infant and Toddler Multivitamin With Iron Drops


name: Clever Choice Comfort EZ 33G 5/32 inch Insulin Pen Needle


name: PERACETIC ACID 8.0 g in 4000 mL TOPICAL LIQUID [Peraflu D]


name: ZINC OXIDE 4.5 g in 50 mL / OCTISALATE 2 g in 50 mL / TITANIUM DIOXIDE 1 g in 50 mL / OCTINOXATE 3 g in 50 mL TOPICAL CREAM [Perfect Shield Rejuve Sunscreen 100]


name: {10 (avatrombopag 20 MG Oral Tablet) } Pack


name: {10 (avatrombopag 20 MG Oral Tablet [Doptelet]) } Pack [Doptelet 40 MG Daily Dose Carton]


name: {15 (avatrombopag 20 MG Oral Tablet) } Pack


name: {15 (avatrombopag 20 MG Oral Tablet [Doptelet]) } Pack [Doptelet 60 MG Daily Dose Carton]


name: AVOBENZONE 1032 mg in 50 mL / HOMOSALATE 2580 mg in 50 mL / OCTINOXATE 3818 mg in 50 mL / OCTOCRYLENE 1548 mg in 50 mL / OXYBENZONE 774 mg in 50 mL TOPICAL CREAM [SHISEIDO BENEFIANCE WRINKLE SMOOTHING DAY]


name: AVOBENZONE 20 mg in 1 g / HOMOSALATE 80 mg in 1 g / OCTOCRYLENE 55 mg in 1 g / OCTISALATE 20 mg in 1 g TOPICAL LIPSTICK [SPF15]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL STICK [SPF30 Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [SPF30 Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL SPRAY [SPF30 Sunscreen]


name: OCTINOXATE 408 mg in 12 g / TITANIUM DIOXIDE 516 mg in 12 g TOPICAL CREAM [cle de peau beaute radiant cream to powder foundation B10]


name: OCTINOXATE 408 mg in 12 g / TITANIUM DIOXIDE 624 mg in 12 g TOPICAL CREAM [cle de peau beaute radiant cream to powder foundation O40]


name: OCTINOXATE 50 mg in 1 mL / OCTISALATE 30 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [NO BS Moisturizer SPF20]


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL CREAM [MD Acne Oil Free SPF 30 Sunscreen]


name: TITANIUM DIOXIDE 60 mg in 1 L / ZINC OXIDE 60 mg in 1 L TOPICAL CREAM [CoralSafe Broad Spectrum SPF30]


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 125 mg in 1 mL TOPICAL CREAM [Miami Beach Body White Gold SPF 50]


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL CREAM [Miami Beach Body SPF-30 Sunscreen]


name: DRESSING,ALGICELL CALCIUM ALGINATE AG 2IN X 2IN


name: BANDAGE KIT,COMPRESSION COFLEX TLC ZINC STANDARD


name: BANDAGE KIT,COMPRESSION COFLEX TLC ZINC LITE


name: CATHERIZATION SET,FOLEY 18FR 30ML BARD #800318


name: FEEDING SET,ENTERAL PUMP ENFIT MEDLINE#ENFIT70550


name: DIALYSATE,NXSTAGE PUREFLOW #RFP-454 SOLN


name: DRESSING,RESTORE,FOAM W/SILICONE 5IN X 6.2IN


name: DRESSING,CUTIMED SORBACT HYDROACTIVE B 5.5IN X 5.5IN #7993302


name: HEAT & MOISTURE EXCHANGER,BLOM-SINGER HME BE1055EF


name: AVOBENZONE 14 mg in 1 g / OCTINOXATE 14 mg in 1 g / OCTOCRYLENE 7 mg in 1 g TOPICAL CREAM [Daily Defence Shield SPF 30]


name: Homosalate 4.75 g in 50 mL / Octocrylene 2.50 g in 50 mL / Octisalate 2.25 g in 50 mL / Avobenzone 1.50 g in 50 mL TOPICAL GEL [Secret Muse Vita Blue Sun]


name: Titanium Dioxide 4.31 g in 20 g / Octisalate 1.40 g in 20 g / Zinc Oxide 0.98 g in 20 g TOPICAL POWDER [May New York Secret Muse Himiznohana Cover Pact No 21]


name: ZINC OXIDE 2.07 g in 23 g / OCTINOXATE 1.38 g in 23 g / OCTISALATE 0.92 g in 23 g / HOMOSALATE 0.69 g in 23 g / TITANIUM DIOXIDE 0.46 g in 23 g TOPICAL POWDER [May New York Secret Muse UV Vita Sun Cushion]


name: OCTINOXATE 20 mg in 1 mL / OXYBENZONE 40 mg in 1 mL / ZINC OXIDE 38 mg in 1 mL TOPICAL LOTION [Wolf Daily Moisturizier SPF 15]


name: SILICON DIOXIDE 15.0 g in 100 g / ALCLOXA 0.16 g in 100 g TOPICAL PASTE, DENTIFRICE [Finefra Tooth]


name: OATMEAL 0.03 g in 1 g TOPICAL CREAM [Epionce Renewal Calming Cream]


name: Dexcom G6 Sensor 3 pack blood-glucose sensor


name: TRILOSTANE 9.9 kg in 10 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: AMANTADINE HYDROCHLORIDE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: AVOBENZONE 30 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / OCTISALATE 20 mg in 1 mL TOPICAL LOTION [Aveeno Positively Radiant Daily Moisturizer Sunscreen Broad Spectrum SPF 15]


name: INSULIN SYRINGE 0.3ML 29G 12MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.3ML 30G 12MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.3ML 30G 8MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.3ML 31G 8MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.5ML 29G 12MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.5ML 30G 12MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.5ML 30G 8MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.5ML 31G 6MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.5ML 31G 8MM (1/2 UNIT MARKINGS)


name: SET,INFUSION AUTOSOFT XC TANDEM #1001680


name: STATLOCK NASOGASTRIC STABILIZATION DEVICE #NG0120


name: SUCTION TUBE ATTACHMENT DEVICE MEDLINE #DYND50144


name: TRACHEAL SUCTION SET 14FR HALYARD #22701356


name: VAD DRIVELINE MAINTENANCE KIT CENTURION #DM185


name: VAD DRIVELINE MAINTENANCE KIT CENTURION #DM190


name: VAD DRIVELINE MAINTENANCE KIT CENTURION #DM810


name: NIACINAMIDE 0.5 g in 25 g / ADENOSINE 0.01 g in 25 g TOPICAL CREAM [RENARDBLANC MULTILAYER MASK]


name: Medical Food Oral Powder for Suspension [GLYTACTIN BUILD 20/20]


name: POLYMYXIN B SULFATE 1 g in 1 g NOT APPLICABLE POWDER


name: Pedialyte AdvancedCare Plus, oral powder for reconstitution


name: multivitamin with minerals combination no.59


name: multivitamin with minerals combination no.60


name: multivitamin with minerals combination no.61


name: multivitamin with minerals combination no.62


name: multivitamin with minerals combination no.63


name: parenteral electrolytes combination no.28


name: colostomy bag, non-sterile 2 1/2"-3" (12") MISCELL EACH


name: nutritional therapy for PKU no.64 6 gram-48 kcal/100 mL ORAL LIQUID (ML)


name: syringe with needle,insulin 0.3 mL (half unit mark) 30 gauge X 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with needle,insulin 0.5 mL (half unit mark) 30 gauge X 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with needle,insulin 0.5 mL (half unit mark) 31 gauge X 15/64" MISCELL SYRINGE, EMPTY DISPOSABLE


name: xanthan gum 48 gram ORAL GEL IN PACKET (GRAM)


name: BENZALKONIUM CHLORIDE 0.12 g in 100 g TOPICAL DRESSING [ANTIBACTERIAL BANDAGES]


name: Adenosine 0.001 g in 2.8 g TOPICAL PATCH [Dermall Matrix Eye zone Dermal care Mask]


name: Adenosine 0.003 g in 8 g TOPICAL PATCH [Dermall Matrix Neck Dermal care Mask]


name: Adenosine 0.014 g in 35 g TOPICAL PATCH [Dermall Matrix Facial Dermal care Mask]


name: panthenol / salicylic acid / zinc pyrithione


name: OCTINOXATE 0.525 g in 7 mL / OXYBENZONE 0.21 g in 7 mL TOPICAL CREAM [Marcelle CC Cream Complete Correction Sunscreen Broad Spectrum SPF 35]


name: TITANIUM DIOXIDE 2 g in 100 mL / ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [Daily Correct CC Cream Broad Sunscreen SPF 35 Light/Medium]


name: OCTINOXATE 3.5 g in 50 g / ZINC OXIDE 2.3 g in 50 g / OCTISALATE 2.25 g in 50 g / TITANIUM DIOXIDE 0.5 g in 50 g TOPICAL CREAM [WIKLAR UV COVER SHIELD]


name: TITANIUM DIOXIDE 2 g in 100 mL / ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [Daily Correct CC Cream Broad Spectrum SPF 35 Light]


name: TITANIUM DIOXIDE 3.2 g in 100 mL / ZINC OXIDE 10.3 g in 100 mL TOPICAL LOTION [Kashmere Anti-aging Sunscreen Moisturizer Broad Spectrum SPF 30]


name: carboxymethylcellulose-Na hyaluronate topical film


name: Chlorpheniramine Maleate/Dextromethorphan Hydrobromide;Dextromethorphan Hydrobromide/Guaifenesin 2 MG/10 ML-15 MG/10 ML; 5 MG/5 ML-100 MG/5 ML Oral Solution


name: IDOXURIDINE 9.9 g in 10 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: LANTHANUM CARBONATE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: MEBENDAZOLE 99 g in 100 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TITANIUM DIOXIDE 2 g in 100 mL / ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [CC Cream Broad Spectrum Sunscreen SPF 35 Fair to Light]


name: OCTINOXATE 2 mg in 1 mL TOPICAL CREAM [Camouflage Concealer Cream]


name: {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Hailey 1.5/30 21 Day]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 3 g in 100 g / OXYBENZONE 4.5 g in 100 g TOPICAL CREAM [Mary Kay TimeWise Age Minimize 3D Day Cream SPF 30 Broad Spectrum Sunscreen (Combo to Oily Skin)]


name: Resident assessment protocol 16--Pressure injuries - triggered


name: Resident assessment protocol 16--Pressure injuries - proceed with care


name: Hepatitis E virus Ab.IgM:PrThr:Pt:Ser/Plas:Ord:IA


name: Peer Rejection Survey version 2.0 - parent report - fixed length form - ages 3-12:-:Pt:^Patient:-:NIH Toolbox


name: Peer Rejection Survey version 2.0 - parent report - fixed length form - ages 3-12


name: Mobility - discharge goal during 3D assessment period


name: Positive Peer Interaction Survey version 2.0 - parent report - fixed length form - ages 3-12:-:Pt:^Patient:-:NIH Toolbox


name: Positive Peer Interaction Survey version 2.0 - parent report - fixed length form - ages 3-12


name: Social Withdrawal Survey version 2.0 - parent report - fixed length form - ages 3-12:-:Pt:^Patient:-:NIH Toolbox


name: Social Withdrawal Survey version 2.0 - parent report - fixed length form - ages 3-12


name: Positive Affect Survey version 2.0 - parent report - CAT item bank - ages 3-7:-:Pt:^Patient:-:NIH Toolbox


name: Positive Affect Survey version 2.0 - parent report - CAT item bank - ages 3-7


name: Sadness Survey version 2.0 - parent report - fixed length form - ages 3-7:-:Pt:^Patient:-:NIH Toolbox


name: Sadness Survey version 2.0 - parent report - fixed length form - ages 3-7


name: Fear-Separation Anxiety Survey version 2.0 - parent report - fixed length form - ages 3-7:-:Pt:^Patient:-:NIH Toolbox


name: Fear-Separation Anxiety Survey version 2.0 - parent report - fixed length form - ages 3-7


name: Fear-Over Anxious Survey version 2.0 - parent report - fixed length form - ages 3-7:-:Pt:^Patient:-:NIH Toolbox


name: Fear-Over Anxious Survey version 2.0 - parent report - fixed length form - ages 3-7


name: Self-Efficacy Survey version 2.0 - CAT item bank - ages 8-12:-:Pt:^Patient:-:NIH Toolbox


name: Self-Efficacy Survey version 2.0 - CAT item bank - ages 8-12


name: General Life Satisfaction Survey version 2.0 - CAT item bank - ages 13-17:-:Pt:^Patient:-:NIH Toolbox


name: General Life Satisfaction Survey version 2.0 - CAT item bank - ages 13-17


name: Positive Affect Survey version 2.0 - fixed length form - ages 8-12:-:Pt:^Patient:-:NIH Toolbox


name: Positive Affect Survey version 2.0 - fixed length form - ages 8-12


name: Sadness Survey version 2.0 - fixed length form - ages 8-17:-:Pt:^Patient:-:NIH Toolbox


name: Sadness Survey version 2.0 - fixed length form - ages 8-17


name: Sadness Survey - CAT item bank - age 18+:-:Pt:^Patient:-:NIH Toolbox


name: Sadness Survey - CAT item bank - age 18+


name: Fear Survey version 2.0 - fixed length form - ages 8-17:-:Pt:^Patient:-:NIH Toolbox


name: Fear Survey version 2.0 - fixed length form - ages 8-17


name: Meaning and Purpose Survey - CAT item bank - age 18+:-:Pt:^Patient:-:NIH Toolbox


name: Meaning and Purpose Survey - CAT item bank - age 18+


name: Current number of unhealed pressure injuries at each stage - follow-up or discharge


name: Porcine circovirus type 2 ORF2 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Senecavirus A VP1 gene:Seq:Pt:Isolate:Nom:Sequencing


name: MDS v3.0 - RAI v1.15.1 - Medications - NOD, NP, SOD, SP:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.15.1 - Medications - NOD, NP, SOD, SP


name: MDS v3.0 - RAI v1.15.1 - Medications - NSD, ND, SSD, SD:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.15.1 - Medications - NSD, ND, SSD, SD


name: Restraints and alarms:-:RptPeriod:^Patient:-:CMS Assessment


name: Other alarm used during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: How much time did you usually spend on one of those D doing vigorous physical activities as part of your work during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D doing vigorous physical activities as part of your work during the last 7D


name: During the last 7D, on how many D did you do moderate physical activities like carrying light loads as part of your work, not including walking, for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you do moderate physical activities like carrying light loads as part of your work, not including walking, for at least 10M at a time


name: How much time did you usually spend on one of those D doing moderate physical activities as part of your work during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D doing moderate physical activities as part of your work during the last 7D


name: Hydrogen/Expired gas^20M post dose lactose PO:VFr:Pt:Exhl gas:Qn


name: Multisection^W contrast IV && Multisection for pulmonary embolus^W contrast IV:Find:Pt:Chest && Chest>Pulmonary arteries:Doc:CT && CT.angio


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Kidney.right:Doc:CT


name: Guidance for percutaneous biopsy:Find:Pt:Chest>Lung.left:Doc:CT


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Kidney.left:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head>Brain && Head>Head vessels:Doc:CT.perfusion && CT.angio


name: Multisection^W contrast IV:Find:Pt:Head && Head>Head vessels & Neck>Neck vessels:Doc:CT && CT.angio


name: Human coronavirus HKU1 RNA:PrThr:Pt:Respiratory.upper:Ord:Probe.amp.tar


name: Human coronavirus OC43 RNA:PrThr:Pt:Respiratory.lower:Ord:Probe.amp.tar


name: Herpes simplex virus identified:Prid:Pt:Respiratory.lower:Nom:Organism specific culture


name: Human coronavirus 229E RNA:PrThr:Pt:Asp:Ord:Probe.amp.tar


name: Human coronavirus 229E RNA:PrThr:Pt:Respiratory.lower:Ord:Probe.amp.tar


name: Degree of difficulty experienced due to your knee while getting on or off toilet in the last W:Find:1W:^Patient:Ord:KOOS


name: Degree of difficulty experienced due to your knee while getting on or off toilet in the last W


name: Degree of difficulty experienced due to your knee while sitting in the last W:Find:1W:^Patient:Ord:KOOS


name: Degree of difficulty experienced due to your knee while sitting in the last W


name: Degree of difficulty experienced due to your knee while getting in or out of bath in the last W:Find:1W:^Patient:Ord:KOOS


name: Degree of difficulty experienced due to your knee while getting in or out of bath in the last W


name: Degree of difficulty experienced due to your knee while lying in bed (turning over, maintaining hip position) in the last W:Find:1W:^Patient:Ord:KOOS


name: Degree of difficulty experienced due to your knee while lying in bed (turning over, maintaining hip position) in the last W


name: Degree of difficulty experienced due to your knee while taking off socks or stockings in the last W:Find:1W:^Patient:Ord:KOOS


name: Degree of difficulty experienced due to your knee while taking off socks or stockings in the last W


name: Provider who performed cardiopulmonary resuscitation:Type:Pt:^Patient:Nom


name: Coagulation factor IX activity actual/Normal:RelCCnc:Pt:PPP:Qn:Chromo


name: Glial nuclear type 1 Ab:ACnc:Pt:Ser:Qn:Line blot


name: Babesia microti Ab.IgG & IgM panel:-:-:Ser:-:IF


name: Amount of knee pain experienced at night while in bed in the last W:Find:1W:^Patient:Ord:KOOS


name: Amount of knee pain experienced at night while in bed in the last W


name: Amount of knee pain experienced while walking on flat surface in the last W:Find:1W:^Patient:Ord:KOOS


name: Amount of knee pain experienced while walking on flat surface in the last W


name: Amount of knee pain experienced while bending knee fully in the last W:Find:1W:^Patient:Ord:KOOS


name: Amount of knee pain experienced while bending knee fully in the last W


name: How often do you experience knee pain:Find:Pt:^Patient:Ord:KOOS


name: How many times have you had chest pain, chest tightness or angina on average over the past 4W:Find:4W:^Patient:Ord:SAQ


name: How many times have you had chest pain, chest tightness or angina on average over the past 4W


name: Lifting or moving heavy objects limited by chest pain, chest tightness or angina over the past 4W:Find:4W:^Patient:Ord:SAQ


name: Lifting or moving heavy objects limited by chest pain, chest tightness or angina over the past 4W


name: Gardening, vacuuming, or carrying groceries limited by chest pain, chest tightness or angina over the past 4W:Find:4W:^Patient:Ord:SAQ


name: Gardening, vacuuming, or carrying groceries limited by chest pain, chest tightness or angina over the past 4W


name: Seattle Angina Questionnaire - 7 items:-:Pt:^Patient:-:SAQ


name: Burkholderia sp identified:Prid:Pt:Respiratory.lower:Nom:Organism specific culture


name: Bordetella sp identified:Prid:Pt:Nph:Nom:Organism specific culture


name: Consultation note:Find:Pt:Adult day care center:Doc:Community health care


name: Discharge summary note:Find:Pt:Adult day care center:Doc:Community health care


name: Note:Find:Pt:Adult day care center:Doc:Community health care


name: Note:Find:Pt:Adult day care center:Doc:Community health care.nurse


name: Microbiology CNAMTS panel:-:Pt:Synv fld:-


name: Connective tissue autoimmune Ab panel:-:Pt:Ser:-


name: Fatty acid omega-3 & omega-6 panel:-:Pt:Ser/Plas:-


name: Guidance for radioembolization for tumor^W Yttrium-90 IA:Find:Pt:Abdomen>Hepatic artery:Doc:{Imaging modality}


name: Guidance for repair of aneurysm:Find:Pt:Abdomen>Aorta.abdominal:Doc:{Imaging modality}


name: Guidance for repair of aneurysm:Find:Pt:Chest>Aorta.thoracic:Doc:{Imaging modality}


name: Guidance for repair of endoleak:Find:Pt:XXX>Artery:Doc:{Imaging modality}


name: Guidance for venous sampling:Find:Pt:Abdomen>Adrenal vein:Doc:{Imaging modality}


name: Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.15.1


name: MDS v3.0 - RAI v1.15.1 - Nursing home & Swing bed OMRA (NO & SO) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home & Swing bed OMRA start of therapy (NS & SS) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home & Swing bed tracking (NT & ST) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home comprehensive (NC) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home discharge (ND) & Swing bed discharge (SD) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home OMRA start of therapy and discharge (NSD) & Swing bed OMRA start of therapy and discharge (SSD) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home OMRA-discharge (NOD) & Swing bed OMRA-discharge (SOD) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home part A PPS discharge (NPE) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home PPS (NP) item set


name: MDS v3.0 - RAI v1.15.1 - Swing bed PPS (SP) item set


name: MDS v3.0 - RAI v1.15.1 - Medications:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Medications received:-:Pt:^Patient:-:CMS Assessment


name: Number of D opiod received in last 7D or since admission &or reentry if less than 7D:Num:7D:^Patient:Qn:CMS Assessment


name: Number of D opiod received in last 7D or since admission &or reentry if less than 7D


name: MDS v3.0 - RAI v1.15.1 - Nursing home quarterly (NQ) item set


name: Glomerular filtration rate/1.73 sq M.predicted.black:ArVRat:Pt:Ser/Plas/Bld:Qn:Creatinine-based formula (CKD-EPI)


name: Glomerular filtration rate/1.73 sq M.predicted.non black:ArVRat:Pt:Ser/Plas/Bld:Qn:Creatinine-based formula (CKD-EPI)


name: Antipsychotic medication review:-:Pt:^Patient:-:CMS Assessment


name: Antipsychotic medications since admission or entry or reentry or the prior OBRA assessment, whichever is more recent:Find:Pt:^Patient:Ord:CMS Assessment


name: Antipsychotic medications since admission or entry or reentry or the prior OBRA assessment, whichever is more recent


name: Gradual dose reduction (GDR) attempted:Find:Pt:^Patient:Ord:CMS Assessment


name: Date of last attempted gradual dose reduction:Date:Pt:^Patient:Qn:CMS Assessment


name: Date of last attempted gradual dose reduction


name: Physician documented GDR as clinically contraindicated:Find:Pt:^Patient:Ord:CMS Assessment


name: Physician documented GDR as clinically contraindicated


name: Date physician documented GDR as clinically contraindicated:Date:Pt:^Patient:Qn:CMS Assessment


name: Date physician documented GDR as clinically contraindicated


name: Bed alarm used during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Chair alarm used during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Floor mat alarm used during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Motion sensor alarm used during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Wander or elopement alarm used during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Multisection for perfusion^WO & W contrast IV && Multisection^W contrast IV:Find:Pt:Head>Brain && Head>Head vessels & Neck>Neck vessels:Doc:CT.perfusion && CT.angio


name: Guidance for percutaneous biopsy:Find:Pt:XXX>Spinal cord:Doc:CT


name: Guidance for percutaneous aspiration of fluid:Find:Pt:Chest:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Chest>Coronary arteries+Pulmonary veins:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Abdomen+Pelvis+Lower extremity.bilateral:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Neck && Head>Head vessels & Neck>Neck vessels:Doc:CT && CT.angio


name: Guidance for stereotactic localization:Find:Pt:XXX:Doc:CT


name: MDS v3.0 - RAI v1.17.2 - Restraints and alarms - NP, ND, SP, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 2.0


name: Mobility - admission performance during 3D assessment period:-:3D:^Patient:-:CMS Assessment


name: Mobility - admission performance during 3D assessment period


name: Mobility - discharge performance during 3D assessment period:-:3D:^Patient:-:CMS Assessment


name: Mobility - discharge performance during 3D assessment period


name: IRF-PAI v3.0 - Skin conditions - discharge:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v3.0 - Skin conditions - discharge


name: Memory &or recall ability during 3D assessment period:Find:3D:^Patient:Nom:CMS Assessment


name: Memory &or recall ability during 3D assessment period


name: Blood pressure with exercise & post exercise panel:-:Pt:Arterial system:Qn


name: Blood pressure with exercise & post exercise panel


name: Transfer summary note:Find:Pt:Long term care facility:Doc:Nurse


name: History and physical note:Find:Pt:{Setting}:Doc:Polytrauma


name: Medical equipment or product note:Find:Pt:{Setting}:Doc:Audiology


name: Actinobacillus pleuropneumoniae Ab.IgG/Positive control:RelRto:Pt:Saliva:Qn:IA


name: Microscopic observation:PrThr:Pt:Vomitus:Ord:Acid fast stain


name: Outcome and assessment information set (OASIS) form - version D, D1 - Transfer to inpatient facility - patient discharged or not discharged:-:Pt:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D, D1 - Transfer to inpatient facility - patient discharged or not discharged


name: Outcome and assessment information set (OASIS) form - version D, D1 - Resumption of care:-:Pt:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D, D1 - Resumption of care


name: Outcome and assessment information set (OASIS) form - version D - Follow-up - recertification or other follow-up:-:Pt:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D - Follow-up - recertification or other follow-up


name: Outcome and assessment information set (OASIS) form - version D, D1 - Discharged from agency - death at home:-:Pt:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D, D1 - Discharged from agency - death at home


name: Outcome and assessment information set (OASIS) form - version D, D1 - Discharged from agency:-:Pt:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D, D1 - Discharged from agency


name: Outcome and assessment information set (OASIS) form - version D:-:Pt:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D


name: Outcome and assessment information set (OASIS) form - version D, D1 - Start of care:-:Pt:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D, D1 - Start of care


name: Chemotherapy infusion start & stop date and time panel:-:Pt:^Patient:-


name: Chemotherapy infusion start & stop date and time panel


name: International Physical Activity Questionnaire self-administered long form:-:Pt:^Patient:-:IPAQ


name: International Physical Activity Questionnaire self-administered long form


name: Job-related physical activity panel:-:Pt:^Patient:-:IPAQ


name: Do you currently have a job or do any unpaid work outside your home:Find:Pt:^Patient:Ord:IPAQ


name: Do you currently have a job or do any unpaid work outside your home


name: During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, digging, heavy construction, or climbing up stairs as part of your work for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, digging, heavy construction, or climbing up stairs as part of your work for at least 10M at a time


name: During the last 7D, on how many D did you walk for at least 10M at a time as a part of your work, not counting any walking you did to travel to or from work:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you walk for at least 10M at a time as a part of your work, not counting any walking you did to travel to or from work


name: How much time did you usually spend on one of those D walking as part of your work during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D walking as part of your work during the last 7D


name: Transportation physical activity panel:-:Pt:^Patient:-:IPAQ


name: During the last 7D, on how many D did you travel in a motor vehicle like a train, bus, car, or tram:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you travel in a motor vehicle like a train, bus, car, or tram


name: How much time did you usually spend on one of those D traveling in a train, bus, car, tram, or other kind of motor vehicle during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D traveling in a train, bus, car, tram, or other kind of motor vehicle during the last 7D


name: During the last 7D, on how many D did you bicycle for at least 10M at a time to go from place to place:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you bicycle for at least 10M at a time to go from place to place


name: How much time did you usually spend on one of those D to bicycle from place to place during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D to bicycle from place to place during the last 7D


name: During the last 7D, on how many D did you walk for at least 10M at a time to go from place to place:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you walk for at least 10M at a time to go from place to place


name: How much time did you usually spend on one of those D walking from place to place during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D walking from place to place during the last 7D


name: Housework, house maintenance, and caring for family panel:-:Pt:^Patient:-:IPAQ


name: Housework, house maintenance, and caring for family panel


name: During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, chopping wood, shoveling snow, or digging in the garden or yard for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, chopping wood, shoveling snow, or digging in the garden or yard for at least 10M at a time


name: How much time did you usually spend on one of those D doing vigorous physical activities in the garden or yard during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D doing vigorous physical activities in the garden or yard during the last 7D


name: During the last 7D, on how many D did you do moderate activities like carrying light loads, sweeping, washing windows, and raking in the garden or yard for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you do moderate activities like carrying light loads, sweeping, washing windows, and raking in the garden or yard for at least 10M at a time


name: How much time did you usually spend on one of those D doing moderate physical activities in the garden or yard during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D doing moderate physical activities in the garden or yard during the last 7D


name: During the last 7D, on how many D did you do moderate activities like carrying light loads, washing windows, scrubbing floors and sweeping inside your home for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you do moderate activities like carrying light loads, washing windows, scrubbing floors and sweeping inside your home for at least 10M at a time


name: How much time did you usually spend on one of those D doing moderate physical activities inside your home during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D doing moderate physical activities inside your home during the last 7D


name: Recreation, sport, and leisure-time physical activity panel:-:Pt:^Patient:-:IPAQ


name: Recreation, sport, and leisure-time physical activity panel


name: Not counting any walking you have already mentioned, during the last 7D, on how many D did you walk for at least 10M at a time in your leisure time:NRat:7D:^Patient:Qn:IPAQ


name: Not counting any walking you have already mentioned, during the last 7D, on how many D did you walk for at least 10M at a time in your leisure time


name: How much time did you usually spend on one of those D walking in your leisure time during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D walking in your leisure time during the last 7D


name: During the last 7D, on how many D did you do vigorous physical activities like aerobics, running, fast bicycling, or fast swimming in your leisure time for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you do vigorous physical activities like aerobics, running, fast bicycling, or fast swimming in your leisure time for at least 10M at a time


name: How much time did you usually spend on one of those D doing vigorous physical activities in your leisure time during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D doing vigorous physical activities in your leisure time during the last 7D


name: During the last 7D, on how many D did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time for at least 10M at a time


name: How much time did you usually spend on one of those D doing moderate physical activities in your leisure time during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D doing moderate physical activities in your leisure time during the last 7D


name: Time spent sitting panel:-:Pt:^Patient:-:IPAQ


name: During the last 7D, how much time did you usually spend sitting on a weekend D:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, how much time did you usually spend sitting on a weekend D


name: International Physical Activity Questionnaire telephone short form:-:Pt:^Patient:-:IPAQ


name: International Physical Activity Questionnaire telephone short form


name: Vigorous physical activity.work domain:ARat:7D:^Patient:Qn:IPAQ


name: Moderate physical activity.work domain:ARat:7D:^Patient:Qn:IPAQ


name: Walking physical activity.work domain:ARat:7D:^Patient:Qn:IPAQ


name: Total physical activity.work domain:ARat:7D:^Patient:Qn:IPAQ


name: Cycle physical activity.active transportation domain:ARat:7D:^Patient:Qn:IPAQ


name: Cycle physical activity.active transportation domain


name: Walking physical activity.active transportation domain:ARat:7D:^Patient:Qn:IPAQ


name: Walking physical activity.active transportation domain


name: Total physical activity.active transportation domain:ARat:7D:^Patient:Qn:IPAQ


name: Total physical activity.active transportation domain


name: Vigorous physical activity.yard work:ARat:7D:^Patient:Qn:IPAQ


name: Moderate physical activity.yard work:ARat:7D:^Patient:Qn:IPAQ


name: Moderate physical activity.inside chores:ARat:7D:^Patient:Qn:IPAQ


name: Moderate physical activity.inside chores


name: Total physical activity.domestic and garden domain:ARat:7D:^Patient:Qn:IPAQ


name: Total physical activity.domestic and garden domain


name: Walking physical activity.leisure-time domain:ARat:7D:^Patient:Qn:IPAQ


name: Walking physical activity.leisure-time domain


name: Vigorous physical activity.leisure-time domain:ARat:7D:^Patient:Qn:IPAQ


name: Vigorous physical activity.leisure-time domain


name: Moderate physical activity.leisure-time domain:ARat:7D:^Patient:Qn:IPAQ


name: Moderate physical activity.leisure-time domain


name: Total physical activity.leisure-time domain:ARat:7D:^Patient:Qn:IPAQ


name: Total physical activity.leisure-time domain


name: International Physical Activity Questionnaire telephone long form:-:Pt:^Patient:-:IPAQ


name: International Physical Activity Questionnaire telephone long form


name: Patient counseling information:-:-:^FDA package insert:Nar


name: How supplied & storage & handling section:-:-:^FDA package insert:Nar


name: How supplied & storage & handling section


name: Cardiopulmonary resuscitation start time:ClockTime:Pt:^Patient:Qn


name: Cardiopulmonary resuscitation start time


name: Hydrogen/Expired gas^10M post dose fructose PO:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^10M post dose lactose PO:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^20M post dose fructose PO:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^40M post dose lactose PO:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^40M post dose fructose PO:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^50M post dose fructose PO:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^50M post dose lactose PO:VFr:Pt:Exhl gas:Qn


name: Babesia divergens+MO-1 strain 18S rRNA gene:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Babesia duncani 18S rRNA gene:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Babesia microti 18S rRNA gene:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: HIV 1 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA:PrThr:Pt:Ser/Plas/Bld^Donor:Ord:Probe.amp.tar


name: California encephalitis virus Ab.IgG & IgM panel:-:Pt:Ser:-:IF


name: California encephalitis virus Ab.IgG & IgM panel


name: California encephalitis virus Ab.IgG+IgM:Imp:Pt:Ser:Ord:IF


name: Herpes simplex virus 1 Ab.IgM:PrThr:Pt:CSF:Ord:IF


name: Mumps virus Ab.IgG & IgM panel:-:Pt:CSF:-:IF


name: Serotonin release 1.0 IU/mL heparin.low molecular weight:ACnc:Pt:Ser:Qn


name: Serotonin release 50 IU/mL heparin.low molecular weight:ACnc:Pt:Ser:Qn


name: Serotonin release 50 IU/mL heparin.low molecular weight


name: Babesia microti & divergens+MO-1 strain & duncani 18S rRNA gene panel:-:Pt:Bld:-:Non-probe.amp.tar


name: Babesia microti & divergens+MO-1 strain & duncani 18S rRNA gene panel


name: OASIS E - Skin Conditions - SOC, ROC:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Integumentary status - discharge from agency:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Integumentary status - discharge from agency


name: Types and sources of assistance - start of care or resumption of care:-:Pt:^Patient:-:CMS Assessment


name: Types and sources of assistance - start of care or resumption of care


name: Deprecated Care management - start of care or resumption of care [CMS Assessment]


name: Care management - start of care or resumption of care


name: Care management - discharge from agency:-:Pt:^Patient:-:CMS Assessment


name: Types and sources of assistance - discarge from agency:-:Pt:^Patient:-:CMS Assessment


name: Types and sources of assistance - discarge from agency


name: How much has your chest pain, chest tightness or angina limited your enjoyment of life over the past 4W:Find:4W:^Patient:Ord:SAQ


name: How much has your chest pain, chest tightness or angina limited your enjoyment of life over the past 4W


name: Quality of life score:Score:Pt:^Patient:Qn:SAQ


name: If you had to spend the rest of your life with your chest pain, chest tightness or angina the way it is right now, how would you feel about this:Find:Pt:^Patient:Ord:SAQ


name: If you had to spend the rest of your life with your chest pain, chest tightness or angina the way it is right now, how would you feel about this


name: How many times have you had to take nitroglycerin (nitroglycerin tablets or spray) for your chest pain, chest tightness or angina on average over the past 4W:Find:4W:^Patient:Ord:SAQ


name: How many times have you had to take nitroglycerin (nitroglycerin tablets or spray) for your chest pain, chest tightness or angina on average over the past 4W


name: Walking indoors on level ground limited by chest pain, chest tightness or angina over the past 4W:Find:4W:^Patient:Ord:SAQ


name: Walking indoors on level ground limited by chest pain, chest tightness or angina over the past 4W


name: Functional abilities and goals - admission:-:Pt:^Patient:-:CMS Assessment


name: Functional abilities and goals - admission


name: Functional abilities and goals - discharge:-:3D:^Patient:-:CMS Assessment


name: Functional abilities and goals - discharge


name: OASIS D - Functional abilities and goals - follow-up:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Functional abilities and goals - follow-up


name: OASIS D - Self-care - follow-up performance:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D - Self-care - follow-up performance


name: OASIS D - Mobility - follow-up performance:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D - Mobility - follow-up performance


name: OASIS D - Patient history and diagnoses - start of care or resumption of care:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Patient history and diagnoses - start of care or resumption of care


name: OASIS E - Diagnoses and symptom control:-:Pt:^Patient:-:CMS Assessment


name: OASIS E - Primary diagnosis:-:Pt:^Patient:-:CMS Assessment


name: OASIS E - Other diagnoses:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Patient history and diagnoses - follow-up:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Patient history and diagnoses - follow-up


name: OASIS D - Sensory status - start of care or resumption of care or follow-up:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Sensory status - start of care or resumption of care or follow-up


name: OASIS D - Integumentary status - start of care or resumption of care


name: OASIS E - Current number of unhealed pressure injuries at each stage - SOC, ROC, FU:-:Pt:^Patient:-:CMS Assessment


name: OASIS E - Current number of unhealed pressure injuries at each stage - SOC, ROC, FU


name: OASIS D - Respiratory status - start of care or resumption of care:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Respiratory status - start of care or resumption of care


name: OASIS E - Bladder and Bowel - SOC, ROC:-:Pt:^Patient:-:CMS Assessment


name: OASIS E - Bladder and Bowel - DC:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Neuro & emotional & behavioral status - start of care or resumption of care:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Neuro & emotional & behavioral status - start of care or resumption of care


name: OASIS D - ADL and IADLs - start of care or resumption of care:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D - ADL and IADLs - start of care or resumption of care


name: OASIS D - ADL and IADLs - discharge from agency:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - ADL and IADLs - discharge from agency


name: OASIS D - Medications - start of care or resumption of care:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Medications - start of care or resumption of care


name: OASIS E - Preferences for Customary Routine Activities - DC:-:Pt:^Patient:-:CMS Assessment


name: OASIS E - Preferences for Customary Routine Activities - DC


name: OASIS D - Therapy need and plan of care:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Data items collected at inpatient facility admission or agency discharge only - transfer:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Data items collected at inpatient facility admission or agency discharge only - transfer


name: OASIS D - Data items collected at inpatient facility admission or agency discharge only - discharge from agency - death at home:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Data items collected at inpatient facility admission or agency discharge only - discharge from agency - death at home


name: OASIS D - Data items collected at inpatient facility admission or agency discharge only - discharge from agency:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Data items collected at inpatient facility admission or agency discharge only - discharge from agency


name: OASIS D - Sensory status - discharge from agency:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Sensory status - discharge from agency


name: OASIS D - Current number of unhealed pressure injuries at each stage - discharge from agency:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Current number of unhealed pressure injuries at each stage - discharge from agency


name: Helicobacter pylori 23S rRNA clarithromycin resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Natural killer cell cytotoxicity.30:1 effector to target cell ratio/Positive control:RelACnc:Pt:Bld MC:Qn


name: Natural killer cell cytotoxicity.30:1 effector to target cell ratio/Positive control


name: Natural killer cell cytotoxicity.0.9:1 effector to target cell ratio/Positive control:RelACnc:Pt:Bld MC:Qn


name: Natural killer cell cytotoxicity.0.9:1 effector to target cell ratio/Positive control


name: Natural killer cell cytotoxicity.15:1 effector to target cell ratio/Positive control:RelACnc:Pt:Bld MC:Qn


name: Natural killer cell cytotoxicity.15:1 effector to target cell ratio/Positive control


name: Natural killer cell cytotoxicity.7.5:1 effector to target cell ratio/Positive control:RelACnc:Pt:Bld MC:Qn


name: Natural killer cell cytotoxicity.7.5:1 effector to target cell ratio/Positive control


name: Natural killer cell cytotoxicity.1.88:1 effector to target cell ratio/Positive control:RelACnc:Pt:Bld MC:Qn


name: Natural killer cell cytotoxicity.1.88:1 effector to target cell ratio/Positive control


name: Natural killer cell cytotoxicity.3.75:1 effector to target cell ratio/Positive control:RelACnc:Pt:Bld MC:Qn


name: Natural killer cell cytotoxicity.3.75:1 effector to target cell ratio/Positive control


name: Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells^^corrected for background:ACnc:Pt:Bld:Qn


name: Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells:ACnc:Pt:Bld:Qn


name: OASIS D - Medications - discharge from agency:-:Pt:^Patient:-:CMS Assessment


name: OASIS D - Medications - discharge from agency


name: IRF-PAI v2.0 - Staff assessment for mental status:-:3D:^Patient:-:CMS Assessment


name: IRF-PAI v2.0 - Staff assessment for mental status


name: IRF-PAI v2.0 - Hearing, speech, and vision - admission:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v2.0 - Hearing, speech, and vision - admission


name: IRF-PAI v2.0 - Quality indicators - admission:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v2.0 - Quality indicators - admission


name: IRF-PAI v2.0 - Cognitive patterns - admission:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v2.0 - Cognitive patterns - admission


name: IRF-PAI v2.0 - Quality indicators - discharge:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v2.0 - Quality indicators - discharge


name: Guidance for percutaneous biopsy:Find:Pt:Chest>Lung.right:Doc:CT


name: Respiratory syncytial virus:PrThr:Pt:Cornea/Conjunctiva:Ord:Organism specific culture


name: Respiratory syncytial virus RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Parainfluenza virus 4 RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Parainfluenza virus identified:Prid:Pt:Cornea/Conjunctiva:Nom:Organism specific culture


name: Human metapneumovirus Identified:Prid:Pt:Cornea/Conjunctiva:Nom:Organism specific culture


name: Varicella zoster virus DNA:PrThr:Pt:Asp:Ord:Probe.amp.tar


name: Enterovirus identified:Prid:Pt:Pericard fld:Nom:Organism specific culture


name: HIV 1 RNA integrase gene mutations detected:Prid:Pt:CSF:Nom:Sequencing


name: HIV 1 RNA protease gene mutations detected:Prid:Pt:CSF:Nom:Sequencing


name: HIV 1 RNA reverse transcriptase gene mutations detected:Prid:Pt:CSF:Nom:Sequencing


name: Parainfluenza virus 2 RNA:PrThr:Pt:Respiratory.lower:Ord:Probe.amp.tar


name: Parainfluenza virus 3 RNA:PrThr:Pt:Respiratory.lower:Ord:Probe.amp.tar


name: Parainfluenza virus 4 RNA:PrThr:Pt:Respiratory.lower:Ord:Probe.amp.tar


name: Parainfluenza virus 1 RNA:PrThr:Pt:Respiratory.lower:Ord:Probe.amp.tar


name: Cytomegalovirus:PrThr:Pt:Bone mar:Ord:Organism specific culture


name: Varicella zoster virus DNA:PrThr:Pt:Respiratory.lower:Ord:Probe.amp.tar


name: Influenza virus identified:Prid:Pt:Respiratory.lower:Nom:Organism specific culture


name: Fetal monosomy X risk:Imp:Pt:Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal 22q11.2 deletion risk:Imp:Pt:Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Bordetella holmesii hIS1001 DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Clostridium botulinum toxin:Prid:Pt:Stool:Nom:Mouse bioassay.neutralization


name: Corynebacterium diphtheriae:PrThr:Pt:Respiratory.upper:Ord:Organism specific culture


name: Legionella sp identified:Prid:Pt:Respiratory.lower:Nom:Organism specific culture


name: Shigella sp identified:Prid:Pt:Stool:Nom:Organism specific culture


name: Clostridium botulinum toxin:Prid:Pt:Ser:Nom:Mouse bioassay.neutralization


name: Influenza virus B RNA:PrThr:Pt:Respiratory.lower:Ord:Probe.amp.tar


name: Human coronavirus HKU1 RNA:PrThr:Pt:Respiratory.lower:Ord:Probe.amp.tar


name: Respiratory syncytial virus A RNA:PrThr:Pt:Respiratory.lower:Ord:Probe.amp.tar


name: Influenza virus B RNA:PrThr:Pt:Pericard fld:Ord:Probe.amp.tar


name: Respiratory syncytial virus B RNA:PrThr:Pt:Respiratory.lower:Ord:Probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Respiratory.lower:Ord:Probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Pericard fld:Ord:Probe.amp.tar


name: Influenza virus A & B RNA panel:-:Pt:Respiratory.lower:-:Probe.amp.tar


name: Human coronavirus 229E RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Human coronavirus 229E RNA:PrThr:Pt:Respiratory.upper:Ord:Probe.amp.tar


name: Human coronavirus HKU1 RNA:PrThr:Pt:Asp:Ord:Probe.amp.tar


name: Human coronavirus HKU1 RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Human coronavirus NL63 RNA:PrThr:Pt:Asp:Ord:Probe.amp.tar


name: Human coronavirus NL63 RNA:PrThr:Pt:Respiratory.lower:Ord:Probe.amp.tar


name: Human coronavirus NL63 RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Human coronavirus NL63 RNA:PrThr:Pt:Respiratory.upper:Ord:Probe.amp.tar


name: Human coronavirus OC43 RNA:PrThr:Pt:Asp:Ord:Probe.amp.tar


name: Human coronavirus OC43 RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Cytomegalovirus:PrThr:Pt:Ocular fld:Ord:Shell vial culture


name: Cytomegalovirus:PrThr:Pt:Amnio fld:Ord:Shell vial culture


name: Cytomegalovirus:PrThr:Pt:Ocular fld:Ord:Organism specific culture


name: Human coronavirus OC43 RNA:PrThr:Pt:Respiratory.upper:Ord:Probe.amp.tar


name: Microscopic observation:PrThr:Pt:Respiratory.lower:Ord:Acid fast stain.Kinyoun


name: Agreement:Find:Pt:Long term care facility:Doc:Nurse


name: Controlled substance agreement:Find:Pt:{Setting}:Doc:Pain medicine


name: Discharge summary note:Find:Pt:Outpatient hospital:Doc:{Role}


name: Parenteral therapy note:Find:Pt:Emergency department:Doc:{Role}


name: Parenteral therapy note:Find:Pt:{Setting}:Doc:Hematology+Medical oncology


name: Parenteral therapy note:Find:Pt:{Setting}:Doc:Internal medicine


name: Acute heart failure within 24H prior to procedure:Hx:24H:^Patient:Ord


name: Coronary artery bypass graft surgery:Hx:Pt:^Patient:Ord


name: Position &or immobilizer used during EMS transport:Find:Pt:^Patient:Nom


name: Herpes simplex virus 1 Ag:PrThr:Pt:Cornea/Conjunctiva:Ord:IF


name: Herpes simplex virus 2 Ag:PrThr:Pt:Cornea/Conjunctiva:Ord:IF


name: Herpes simplex virus Ag:PrThr:Pt:CSF:Ord:IF


name: Herpes simplex virus Ag:PrThr:Pt:Cornea/Conjunctiva:Ord:IF


name: Pneumocystis jiroveci:PrThr:Pt:Respiratory.lower:Ord:Calcofluor white preparation


name: Admission evaluation note:Find:Pt:Patient's home:Doc:Primary care


name: Discharge summary note:Find:Pt:Patient's home:Doc:{Role}


name: Discharge teaching note:Find:Pt:Patient's home:Doc:{Role}


name: Used bowel toileting program:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Ulcers, wounds and skin problems in the last 7D:Find:7D:^Patient:Nom:CMS Assessment


name: Ulcers, wounds and skin problems in the last 7D


name: Electrolytes & Osmolality panel:-:Pt:Stool:Qn


name: Protein fractions panel:-:Pt:Body fld:-:Electrophoresis


name: Procainamide & N-acetylprocainamide panel:-:Pt:Ser/Plas:-


name: Procainamide & N-acetylprocainamide panel


name: Babesia microti Ab.IgG & IgM:Imp:Pt:Ser:Nom


name: Norovirus genogroups I & II RNA panel:-:Pt:Stool:-:Probe.amp.tar


name: Bedaquiline:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Kanamycin 3.5 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Linezolid 1.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Moxifloxacin 0.25 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Dermatophagoides pteronyssinus recombinant (rDer p) 1 Ab.IgE:ACnc:Pt:Ser:Qn


name: Dermatophagoides pteronyssinus recombinant (rDer p) 1 Ab.IgE